iShares Genomics Immunology and Healthcare ETF (NYSEARCA:IDNA) Stock Price Down 1.3% – Should You Sell?

iShares Genomics Immunology and Healthcare ETF (NYSEARCA:IDNA) fell 1.3% on Tuesday . The company traded as low as $21.48 and last traded at $21.78. 17,987 shares traded hands during mid-day trading, a decline of 41% from the average session volume of 30,319 shares. The stock had previously closed at $22.06.

iShares Genomics Immunology and Healthcare ETF Trading Down 1.0 %

The stock’s 50 day moving average is $22.54 and its two-hundred day moving average is $23.59. The stock has a market capitalization of $112.06 million, a price-to-earnings ratio of 23.93 and a beta of 1.03.

Institutional Inflows and Outflows

A hedge fund recently raised its stake in iShares Genomics Immunology and Healthcare ETF stock. Ameriprise Financial Inc. increased its holdings in shares of iShares Genomics Immunology and Healthcare ETF (NYSEARCA:IDNA) by 23.6% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 71,832 shares of the company’s stock after purchasing an additional 13,721 shares during the quarter. Ameriprise Financial Inc. owned approximately 1.23% of iShares Genomics Immunology and Healthcare ETF worth $1,626,000 as of its most recent SEC filing.

About iShares Genomics Immunology and Healthcare ETF

The iShares Genomics Immunology and Healthcare ETF (IDNA) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund tracks a market-cap-selected and -weighted index of global stocks involved in genomics, immunology, and bioengineering. IDNA was launched on Jun 11, 2019 and is managed by BlackRock.